Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovidrel vs Urinary hCG for Final Follicle Maturation in Chinese Women Undergoing IVF/ET
NCT01081756Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Dec 2003
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of choriogonadotropin alfa in infertility, sponsored by Merck KGaA. Started Dec 2003; status: completed.
02
Drugs
choriogonadotropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01081756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081756.